Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model (Q40957597)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 1999

Language	Label	Description	Also known as
English	Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model	scientific article published on March 1999

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model (English)

1 reference

Europe PubMed Central

25 September 2017

vector-borne disease

0 references

Semliki Forest virus

0 references

author name string

Notka F

1

1 reference

Europe PubMed Central

25 September 2017

Stahl-Hennig C

2

1 reference

Europe PubMed Central

25 September 2017

Dittmer U

3

1 reference

Europe PubMed Central

25 September 2017

Wolf H

4

1 reference

Europe PubMed Central

25 September 2017

Wagner R

5

1 reference

Europe PubMed Central

25 September 2017

publication date

1 March 1999

1 reference

Europe PubMed Central

25 September 2017

Biological Chemistry

1 reference

Europe PubMed Central

25 September 2017

380

1 reference

Europe PubMed Central

25 September 2017

3

1 reference

Europe PubMed Central

25 September 2017

341-352

1 reference

Europe PubMed Central

25 September 2017

Semliki Forest virus expression system: production of conditionally infectious recombinant particles.

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Clearance of HIV infection in a perinatally infected infant

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

The protease and gag gene products of the human immunodeficiency virus: authentic cleavage and post-translational modification in an insect cell expression system

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Can the immune response control HIV infection?

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Modification and secretion of human interleukin 2 produced in insect cells by a baculovirus expression vector

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.046

21 January 2018

Identifiers

10.1515/BC.1999.046

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40957597&oldid=1911135852"